Talmi Y P, Bedrin L, Waller A, Horowitz Z, Skurnik Y, Adunski A, Kronenberg J
Department of Otolaryngology-Head and Neck Surgery, Chaim Sheba Medical Center, Tel Hashomer, Israel.
J Laryngol Otol. 1998 Mar;112(3):252-7. doi: 10.1017/s0022215100158293.
Synchronous or metachronous second primary malignancies of the lung are sometimes encountered in patients with laryngeal cancer while the occurrence of a laryngeal second primary following cancer of the lung is rare. A two-armed study was conducted. A prospective arm in which the larynges of 56 terminal lung cancer patients were examined, and a retrospective arm incorporating both a chart study of 126 terminal head and neck cancer patients (HNCP) and a computerized search of all hospital records of patients with laryngeal and lung cancers. No laryngeal malignancy was found in the lung cancer patients' group and no antedating pulmonary malignancy was recorded in the terminal HNCP. The computerized search of 1778 lung cancer patients and 213 laryngeal cancer patients also failed to demonstrate cases where the former preceded the latter. In conclusion. No second primary of the larynx was found in lung cancer patients. These results compare with reports of large databases where cancer of the larynx was found in a negligible percentage of lung cancer survivors and theories explaining this are discussed.
喉癌患者有时会出现同步或异时性的肺部第二原发性恶性肿瘤,而肺癌后发生喉第二原发性肿瘤则很少见。进行了一项双臂研究。前瞻性研究中检查了56例终末期肺癌患者的喉部,回顾性研究纳入了126例终末期头颈癌患者(HNCP)的病历研究以及对所有喉癌和肺癌患者医院记录的计算机检索。肺癌患者组中未发现喉部恶性肿瘤,终末期HNCP中也未记录到先前存在的肺部恶性肿瘤。对1778例肺癌患者和213例喉癌患者的计算机检索也未能证明前者先于后者的病例。总之,肺癌患者中未发现喉第二原发性肿瘤。这些结果与大型数据库的报告相符,在大型数据库中,肺癌幸存者中发现喉癌的比例可忽略不计,并讨论了解释这一现象的理论。